CytoDyn will host a webcast on April 6th to provide a full update on its business
VANCOUVER, Wash., April 1, 2021 (GLOBE NEWSWIRE) - CytoDyn Inc. (OTC.QB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing Vyrologix ™ (leronlimab-PRO 140)) , a CCR5…